Related Experiment Video
Updated: Jul 15, 2025

Author Spotlight: Advancements in Retroperitoneal Approach for Necrotizing Pancreatitis
Published on: March 15, 2024
Multidisciplinary management of acute cholecystitis during the COVID-19 pandemic
Insights
The COVID-19 pandemic lockdown saw a 72.8% rise in acute cholecystitis (AC) admissions. Gallbladder perforation and readmissions increased, with younger patients and more frequent percutaneous transhepatic gallbladder drainage (PTGBD).
Area of Science:
- Gastroenterology and Hepatology
- Surgical Outcomes
- Epidemiology
Background:
- The COVID-19 pandemic significantly disrupted healthcare services globally.
- Acute cholecystitis (AC) management may have been affected by public health measures like lockdowns.
- Assessing AC outcomes during the pandemic is crucial for understanding healthcare system impacts.
Purpose of the Study:
- To evaluate the clinical outcomes of acute cholecystitis during the COVID-19 pandemic's nationwide lockdown.
- To compare patient demographics, AC severity, treatment strategies, and outcomes between the lockdown period and a pre-pandemic historical control period.
Main Methods:
- A comparative study analyzing patients admitted for AC.
- Data collected included patient characteristics, Charlson Comorbidity Index (CCI), AC severity, treatment modality, and outcomes.
- Comparison between a lockdown period (April 2020-November 2021) and a historical control period (May 2017-December 2018).
Main Results:
- AC admissions increased by 72.8% during the lockdown period.
- Patients during lockdown were younger and had a higher prevalence in the CCI 1 group.
- Higher rates of gallbladder perforation (GP) and unplanned readmissions were observed during lockdown, alongside increased use of percutaneous transhepatic gallbladder drainage (PTGBD).
Conclusions:
- The nationwide COVID-19 lockdown was associated with a significant increase in acute cholecystitis prevalence.
- Gallbladder perforation and unplanned readmissions were more frequent during the lockdown period.
- Treatment trends shifted towards more invasive procedures like PTGBD, with less frequent successful conservative management.
Abstract:
The coronavirus disease 2019 pandemic had a major impact on most medical services. Our aim was to assess the outcome of acute cholecystitis during the nationwide lockdown period. All patients admitted to our emergency department for AC were analysed. Patient characteristics, performance status, AC severity, treatment modality and outcome of AC were assessed during the lockdown period (Period II: 1 April 2020-30 November 2021) and compared to a historical control period (Period I: 1 May 2017-31 December 2018). AC admissions increased by 72.8% in Period II. Patients were younger (70 vs. 74 years, p = 0.017) and greater in number in the CCI 1 group (20.4% vs. 11.2%, p = 0.043) in Period II. The unplanned readmission rate (6.3 vs. 0%, p = 0.004) and the gallbladder perforation (GP) rate was higher (18.0 vs. 7.3%, p = 0.006) in Period II. Percutaneous transhepatic gallbladder drainage (PTGBD) was more frequent (24.1 vs. 12.8%, p = 0.012) in Period II. In addition to a drop in patient age and CCI, a significant rise in the prevalence of acute cholecystitis, GP and unplanned readmissions was observed during the nationwide lockdown due to the COVID-19 pandemic. PTGBD was more frequent during this period, whereas successful conservative treatment was less frequent.
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Acute Pancreatitis II: Clinical Manifestations and Management
Appendicitis-II: Diagnostic Studies and Management
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Acute Coronary Syndrome IV: Interprofessional Care
Pericarditis III: Medical Management
